EmtricitabinTenofovirdisoproxil

Hauptinformation

  • Handelsname:
  • Emtricitabin/Tenofovirdisoproxil Hormosan 200 mg/245 mg Filmtabletten
  • Darreichungsform:
  • Filmtablette
  • Zusammensetzung:
  • Emtricitabin 200.mg; Tenofovirdisoproxilphosphat 291.mg
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Emtricitabin/Tenofovirdisoproxil Hormosan 200 mg/245 mg Filmtabletten
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • 96985.00.00
  • Letzte Änderung:
  • 12-02-2018

3-5-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [American Health Packaging]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [American Health Packaging]

Updated Date: May 3, 2018 EST

US - DailyMed

25-4-2018

Viread (Gilead Sciences International Limited)

Viread (Gilead Sciences International Limited)

Viread (Active substance: tenofovir disoproxil fumarate) - Centralised - Yearly update - Commission Decision (2018)2598 of Wed, 25 Apr 2018

Europe -DG Health and Food Safety

23-4-2018

Descovy (Gilead Sciences International Limited)

Descovy (Gilead Sciences International Limited)

Descovy (Active substance: emtricitabine / tenofovir alafenamide) - Centralised - Yearly update - Commission Decision (2018)2497 of Mon, 23 Apr 2018

Europe -DG Health and Food Safety

23-4-2018

Stribild (Gilead Sciences International Limited)

Stribild (Gilead Sciences International Limited)

Stribild (Active substance: elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)) - Centralised - Renewal - Commission Decision (2018)2505 of Mon, 23 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2574/R/86

Europe -DG Health and Food Safety

27-3-2018

Atripla (Bristol-Myers Squibb and Gilead Sciences Limited)

Atripla (Bristol-Myers Squibb and Gilead Sciences Limited)

Atripla (Active substance: efavirenz / emtricitabine / tenofovir disoproxil fumarate) - Centralised - 2-Monthly update - Commission Decision (2018)1953 of Tue, 27 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/797/II/127/G

Europe -DG Health and Food Safety

6-3-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet, Coated [Apotex Corp.]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Coated [Apotex Corp.]

Updated Date: Mar 6, 2018 EST

US - DailyMed

28-2-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Laurus Labs Limited]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Laurus Labs Limited]

Updated Date: Feb 28, 2018 EST

US - DailyMed

21-2-2018

Tenofovir disoproxil Mylan (Mylan S.A.S.)

Tenofovir disoproxil Mylan (Mylan S.A.S.)

Tenofovir disoproxil Mylan (Active substance: Tenofovir disoproxil) - Centralised - Yearly update - Commission Decision (2018)1120 of Wed, 21 Feb 2018

Europe -DG Health and Food Safety

15-2-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Camber Pharmaceuticals, Inc.]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Camber Pharmaceuticals, Inc.]

Updated Date: Feb 15, 2018 EST

US - DailyMed

12-2-2018

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (Krka d. d., Novo Mesto)

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (Krka d. d., Novo Mesto)

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (Active substance: efavirenz / emtricitabine / tenofovir disoproxil) - Centralised - Authorisation - Commission Decision (2018)901 of Mon, 12 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4274

Europe -DG Health and Food Safety

7-2-2018

Truvada (Gilead Sciences International Limited)

Truvada (Gilead Sciences International Limited)

Truvada (Active substance: emtricitabine / tenofovir disoproxil fumarate) - Centralised - 2-Monthly update - Commission Decision (2018)731 of Wed, 07 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/594/II/135

Europe -DG Health and Food Safety

5-2-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet [REMEDYREPACK INC.]

TENOFOVIR DISOPROXIL FUMARATE Tablet [REMEDYREPACK INC.]

Updated Date: Feb 5, 2018 EST

US - DailyMed

30-1-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet [Strides Shasun Limited]

TENOFOVIR DISOPROXIL FUMARATE Tablet [Strides Shasun Limited]

Updated Date: Jan 30, 2018 EST

US - DailyMed

29-1-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet [Cipla USA Inc.]

TENOFOVIR DISOPROXIL FUMARATE Tablet [Cipla USA Inc.]

Updated Date: Jan 29, 2018 EST

US - DailyMed

29-1-2018

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Aurobindo Pharma Limited]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Aurobindo Pharma Limited]

Updated Date: Jan 29, 2018 EST

US - DailyMed

22-1-2018

Tenofovir disoproxil Zentiva (Zentiva, k.s.)

Tenofovir disoproxil Zentiva (Zentiva, k.s.)

Tenofovir disoproxil Zentiva (Active substance: tenofovir disoproxil) - Centralised - Yearly update - Commission Decision (2018)417 of Mon, 22 Jan 2018

Europe -DG Health and Food Safety

22-12-2017

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [REMEDYREPACK INC.]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [REMEDYREPACK INC.]

Updated Date: Dec 22, 2017 EST

US - DailyMed

19-12-2017

Eviplera (Gilead Sciences International Limited)

Eviplera (Gilead Sciences International Limited)

Eviplera (Active substance: emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)) - Centralised - 2-Monthly update - Commission Decision (2017)8907 of Tue, 19 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2312/WS/1251

Europe -DG Health and Food Safety

15-12-2017

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Teva Pharmaceuticals USA, Inc.]

TENOFOVIR DISOPROXIL FUMARATE Tablet, Film Coated [Teva Pharmaceuticals USA, Inc.]

Updated Date: Dec 15, 2017 EST

US - DailyMed

13-12-2017

Odefsey (Gilead Sciences International Limited)

Odefsey (Gilead Sciences International Limited)

Odefsey (Active substance: emtricitabine / rilpivirine / tenofovir alafenamide) - Centralised - 2-Monthly update - Commission Decision (2017)8696 of Wed, 13 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4156/WS/1251

Europe -DG Health and Food Safety

17-11-2017

Emtricitabine/Tenofovir disoproxil Krka (Krka d. d., Novo Mesto)

Emtricitabine/Tenofovir disoproxil Krka (Krka d. d., Novo Mesto)

Emtricitabine/Tenofovir disoproxil Krka (Active substance: emtricitabine / tenofovir disoproxil) - Centralised - 2-Monthly update - Commission Decision (2017)7740 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4215/IB/5G

Europe -DG Health and Food Safety

14-11-2017

Emtricitabine /Tenofovir disoproxil Krka d.d. (Krka d. d., Novo Mesto)

Emtricitabine /Tenofovir disoproxil Krka d.d. (Krka d. d., Novo Mesto)

Emtricitabine /Tenofovir disoproxil Krka d.d. (Active substance: emtricitabine / tenofovir disoproxil) - Centralised - 2-Monthly update - Commission Decision (2017)7633 of Tue, 14 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4686/IB/2/G

Europe -DG Health and Food Safety